HDS Plus PBPC Transplant Vs 4 More Courses of FrontLine Therapy in Pts With Aggressive NHL in PR After Induction Therapy
PHASE3CompletedINTERVENTIONAL
Enrollment
441
Participants
Timeline
Start Date
October 31, 2000
Study Completion Date
April 30, 2008
Conditions
High-Grade Lymphomas
Interventions
DRUG
HDS vs ProMECE/CytaBOM
Trial Locations (1)
41100
GISL Trial Office, Modena
All Listed Sponsors
lead
Gruppo Italiano Studio Linfomi
OTHER
NCT00866203 - HDS Plus PBPC Transplant Vs 4 More Courses of FrontLine Therapy in Pts With Aggressive NHL in PR After Induction Therapy | Biotech Hunter | Biotech Hunter